Guobang Pharma Ltd. (605507.SS)
CNY 20.45
(0.34%)
CNY 20.45
(0.34%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 5.34 Billion | 5.72 Billion | 4.5 Billion | 4.2 Billion | 3.8 Billion | 3.27 Billion |
| Cost of Revenue | 4.14 Billion | 4.14 Billion | 3.14 Billion | 2.75 Billion | 2.81 Billion | 2.3 Billion |
| Gross Profit | 1.2 Billion | 1.57 Billion | 1.35 Billion | 1.45 Billion | 986.19 Million | 974.68 Million |
| Operating Expenses | 550.06 Million | 575.06 Million | 478.98 Million | 420.85 Million | 394.57 Million | 353.75 Million |
| Selling, General and Administrative Expenses | 154.1 Million | 155.65 Million | 147.43 Million | 135.07 Million | 129.8 Million | 115.85 Million |
| Research and Development Expenses | 191.99 Million | 197.54 Million | 155.27 Million | 137.18 Million | 124.34 Million | 103.29 Million |
| Other Expenses | -43.48 Million | 221.86 Million | 176.27 Million | 148.59 Million | 140.42 Million | -17.86 Million |
| Cost and Expenses | 4.64 Billion | 4.71 Billion | 3.62 Billion | 3.17 Billion | 3.21 Billion | 2.65 Billion |
| Operating Income | 702.26 Million | 1.05 Billion | 808.77 Million | 936.11 Million | 581.58 Million | 579.69 Million |
| Interest Expense | 27.54 Million | 16.54 Million | 28.72 Million | 35.51 Million | 33.74 Million | 33.2 Million |
| Income Tax Expense | 87.66 Million | 115.01 Million | 100.55 Million | 133.14 Million | 81.91 Million | 78.36 Million |
| Earnings before Tax | 697.64 Million | 1.03 Billion | 806.78 Million | 943.43 Million | 575.92 Million | 561.82 Million |
| Net Income | 612.46 Million | 920.9 Million | 706.03 Million | 810 Million | 494 Million | 210.87 Million |
| Earnings Per Share Basic | 1.10 | 1.65 | 1.26 | 1.45 | 0.88 | 0.44 |
| Earnings Per Share Diluted | 1.10 | 1.65 | 1.26 | 1.45 | 0.88 | 0.44 |
| Weighted Average Shares Outstanding | 556.78 Million | 558.82 Million | 558.82 Million | 558.82 Million | 558.82 Million | 477.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 556.78 Million | 558.82 Million | 558.82 Million | 558.82 Million | 558.82 Million | 477.18 Million |
| Gross Margin | 0.23 | 0.28 | 0.30 | 0.34 | 0.26 | 0.30 |
| EBIT Margin | 0.19 | 0.24 | 0.24 | 0.27 | 0.20 | 0.24 |
| Profit Margin | 0.11 | 0.16 | 0.16 | 0.19 | 0.13 | 0.06 |
| EBITDA | 1.04 Billion | 1.31 Billion | 1.04 Billion | 1.13 Billion | 748.69 Million | 728.04 Million |
| Earnings Before Tax Margin | 0.13 | 0.18 | 0.18 | 0.22 | 0.15 | 0.18 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1.52 Billion | 1.54 Billion | 1.33 Billion | 5.34 Billion | 1.29 Billion | 1.24 Billion |
| Cost of Revenue | 1.13 Billion | 1.17 Billion | 971.46 Million | 4.09 Billion | 1.04 Billion | 936.69 Million |
| Gross Profit | 386.89 Million | 367.5 Million | 367.24 Million | 1.25 Billion | 253.02 Million | 307.05 Million |
| Operating Expenses | 168.99 Million | 168.18 Million | 133.66 Million | 593.18 Million | 129.34 Million | 168.14 Million |
| Selling, General and Administrative Expenses | 211.5 Million | 80.17 Million | 92.97 Million | - | -105.82 Million | 203.83 Million |
| Research and Development Expenses | 67.32 Million | 52.29 Million | 37.65 Million | - | 27.74 Million | 65.32 Million |
| Other Expenses | -109.83 Million | -35.7 Million | -2.08 Million | 5.7 Million | 10.13 Million | 1.12 Million |
| Cost and Expenses | 1.3 Billion | 1.34 Billion | 1.1 Billion | 4.69 Billion | 1.17 Billion | 1.1 Billion |
| Operating Income | 201.48 Million | 199.31 Million | 236.1 Million | 702.26 Million | 138.28 Million | 146.45 Million |
| Interest Expense | 6.86 Million | 7.35 Million | 7.42 Million | 22.58 Million | 4.38 Million | 8.71 Million |
| Income Tax Expense | 26.27 Million | 24.27 Million | 35.44 Million | 87.66 Million | 15.77 Million | 15.84 Million |
| Earnings before Tax | 200.54 Million | 229.82 Million | 234.02 Million | 697.64 Million | 138.09 Million | 146.64 Million |
| Net Income | 174.28 Million | 205.86 Million | 198.73 Million | 612.46 Million | 123.39 Million | 131.6 Million |
| Earnings Per Share Basic | 0.32 | 0.37 | 0.36 | - | 0.22 | 0.24 |
| Earnings Per Share Diluted | 0.32 | 0.37 | 0.36 | - | 0.22 | 0.24 |
| Weighted Average Shares Outstanding | 552.69 Million | 552.69 Million | 552.03 Million | 556.78 Million | 558.82 Million | 558.82 Million |
| Weighted Average Shares Outstanding (Diluted) | 552.69 Million | 552.69 Million | 552.03 Million | 556.78 Million | 558.82 Million | 558.82 Million |
| Gross Margin | 0.25 | 0.24 | 0.27 | 0.23 | 0.20 | 0.25 |
| EBIT Margin | 0.14 | 0.20 | 0.19 | - | 0.11 | 0.13 |
| Profit Margin | 0.11 | 0.13 | 0.15 | 0.11 | 0.10 | 0.11 |
| EBITDA | 207.4 Million | 302.21 Million | 255.15 Million | - | 148.12 Million | 159.26 Million |
| Earnings Before Tax Margin | 0.13 | 0.13 | 0.18 | 0.13 | 0.11 | 0.12 |
600063
BLBLF
ENGNW
0104
ASHOKRE
DAULAT